Patents Assigned to ViiV Healthcare UK Limited
  • Benzoazepine derivatives
    Patent number: 10239840
    Abstract: Compounds of Formula I are disclosed and methods of treating viral infections with compositions comprising such compounds.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: March 26, 2019
    Assignee: VIIV HEALTHCARE UK LIMITED
    Inventors: Brian Alvin Johns, Lita S. Suwandi, Emile Johann Velthuisen, Jason Gordon Weatherhead
  • Isoindolinone derivatives useful as antiviral agents
    Patent number: 10118894
    Abstract: Compounds of Formula I are disclosed and methods of treating viral infections with compositions comprising such compounds.
    Type: Grant
    Filed: July 20, 2015
    Date of Patent: November 6, 2018
    Assignee: ViiV HEALTHCARE UK LIMITED
    Inventors: Brian Alvin Johns, Emile Johann Velthuisen, Jason Gordon Weatherhead
  • Isoindoline derivatives for use in the treatment of a viral infection
    Patent number: 10112899
    Abstract: Compounds of Formula I are disclosed and methods of treating viral infections with compositions comprising such compounds.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: October 30, 2018
    Assignee: ViiV HEALTHCARE UK LIMITED
    Inventors: Brian Alvin Johns, Emile Johann Velthuisen, Jason Gordon Weatherhead, Lita Suwandi, David Temelkoff
  • Phenyl and tertbutylacetic acid substituted pyridinones having anti-HIV effects
    Patent number: 9802898
    Abstract: Compounds of Formula I are disclosed and methods of treating viral infections with compositions comprising such compounds.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: October 31, 2017
    Assignee: ViiV HEALTHCARE UK LIMITED
    Inventors: Brian Alvin Johns, Emile Johann Velthuisen
  • INHIBITORS OF HIV REPLICATION
    Publication number: 20160355528
    Abstract: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.
    Type: Application
    Filed: August 19, 2016
    Publication date: December 8, 2016
    Applicant: VIIV HEALTHCARE UK LIMITED
    Inventors: Andrew Simon BELL, Iain Brian GARDNER, Karl Richard GIBSON, David Cameron PRYDE, Florian Michel WAKENHUT
  • Inhibitors of HIV replication
    Patent number: 9447116
    Abstract: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.
    Type: Grant
    Filed: July 2, 2014
    Date of Patent: September 20, 2016
    Assignee: ViiV Healthcare UK Limited
    Inventors: Andrew Simon Bell, Iain Brian Gardner, Karl Richard Gibson, David Cameron Pryde, Florian Michel Wakenhut
  • Compounds and methods for treating HIV
    Patent number: 9163023
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: July 10, 2013
    Date of Patent: October 20, 2015
    Assignee: ViiV Healthcare UK Limited
    Inventors: Martha Alicia De La Rosa, Brian Alvin Johns, Wieslaw Mieczyslaw Kazmierski, Vicente Samano, Lita Suwandi, David Temelkoff, Emile Velthuisen, Jason Gordon Weatherhead
  • Isoquinoline compounds and methods for treating HIV
    Patent number: 9029391
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: January 23, 2012
    Date of Patent: May 12, 2015
    Assignee: ViiV Healthcare UK Limited
    Inventors: Martha Alicia De La Rosa, Simon Haydar, Brian Alvin Johns, Emile Johann Velthuisen
  • Pyrrolopyridinone compounds and methods for treating HIV
    Patent number: 9012642
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Grant
    Filed: September 18, 2012
    Date of Patent: April 21, 2015
    Assignee: ViiV Healthcare UK Limited
    Inventors: Simon N. Haydar, Brian Alvin Johns, Emile Johann Velthuisen
  • Inhibitors of HIV replication
    Patent number: 8809363
    Abstract: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.
    Type: Grant
    Filed: November 14, 2011
    Date of Patent: August 19, 2014
    Assignee: VIIV Healthcare UK Limited
    Inventors: Andrew Simon Bell, Iain Brian Gardner, Karl Richard Gibson, David Cameron Pryde, Florian Michel Wakenhut
  • Isoquinoline Compounds And Methods For Treating HIV
    Publication number: 20130289027
    Abstract: Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).
    Type: Application
    Filed: January 23, 2012
    Publication date: October 31, 2013
    Applicant: ViiV Healthcare UK Limited
    Inventors: Martha Alicia De La Rosa, Simon Haydar, Brian Alvin Johns, Emile Johann Velthuisen